Skip to main content

Table 1 Possible exosomal miRNAs as tumor biomarker

From: Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications

Cancer

miRNAs considered as biomarkers

Source

Reference

Acute myeloid leukemia

miR-150, miR-1246, miR-155

Serum

[90]

Bladder

miR-15b, miR-24, miR-135b, miR-1224-3p

Urine

[91]

miR-21, miR-4454

Urine

[92]

Breast

miR-200a, miR-200c, miR-205

Serum

[93]

miR-10, miR-21, miR-182, miR-373, miR-1246

Serum

[94]

Cervical

miR-21, miR-146a

Cervical lavages

[95]

Colorectal

miR-23a, miR-1229, miR-1246, miR-let-7a, miR-150, miR-21, miR-223

Serum

[96]

let7a, miR-21, miR-192, miR-221

Serum

[97]

Esophageal

miRNA-21

Serum

[98]

Glioma

miR-320, miR-574-3p

Serum

[99]

miR-21

CSF

[100]

Lung

miR-155,miR-17-3p, miR-205, miR-21, miR-106a, miR-146, miR-191, miR-192, miR-212, miR-214 miR-203, miR-210

Plasma and Bronchoalveolar

[101]